342 related articles for article (PubMed ID: 27704554)
21. A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic Model.
Mahmood I
Drugs R D; 2020 Dec; 20(4):377-387. PubMed ID: 33150526
[TBL] [Abstract][Full Text] [Related]
22. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.
Peeters MY; Allegaert K; Blussé van Oud-Alblas HJ; Cella M; Tibboel D; Danhof M; Knibbe CA
Clin Pharmacokinet; 2010 Apr; 49(4):269-75. PubMed ID: 20214410
[TBL] [Abstract][Full Text] [Related]
23. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.
Ginsberg G; Hattis D; Russ A; Sonawane B
J Toxicol Environ Health A; 2004 Feb; 67(4):297-329. PubMed ID: 14713563
[TBL] [Abstract][Full Text] [Related]
24. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145
[TBL] [Abstract][Full Text] [Related]
25. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
T'jollyn H; Vermeulen A; Van Bocxlaer J
AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
[TBL] [Abstract][Full Text] [Related]
26. Prediction of drug clearance in children 3 months and younger: an allometric approach.
Mahmood I
Drug Metabol Drug Interact; 2010; 25(1-4):25-34. PubMed ID: 21417791
[TBL] [Abstract][Full Text] [Related]
27. Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds.
Li R; Maurer TS; Sweeney K; Barton HA
AAPS J; 2016 May; 18(3):746-56. PubMed ID: 26951483
[TBL] [Abstract][Full Text] [Related]
28. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
29. Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method.
Calvier EAM; Krekels EHJ; Johnson TN; Rostami-Hodjegan A; Tibboel D; Knibbe CAJ
AAPS J; 2019 Mar; 21(3):38. PubMed ID: 30850923
[TBL] [Abstract][Full Text] [Related]
30. Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric Patients.
Mahmood I; Tegenge MA
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S108-S116. PubMed ID: 34185903
[TBL] [Abstract][Full Text] [Related]
31. The Predictive Value of Glomerular Filtration Rate-Based Scaling of Pediatric Clearance and Doses for Drugs Eliminated by Glomerular Filtration with Varying Protein-Binding Properties.
Cristea S; Krekels EHJ; Allegaert K; Knibbe CAJ
Clin Pharmacokinet; 2020 Oct; 59(10):1291-1301. PubMed ID: 32314184
[TBL] [Abstract][Full Text] [Related]
32. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
Yun YE; Edginton AN
J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
[TBL] [Abstract][Full Text] [Related]
33. Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants.
Duan P; Fisher JW; Yoshida K; Zhang L; Burckart GJ; Wang J
Clin Pharmacokinet; 2017 Apr; 56(4):383-394. PubMed ID: 27596256
[TBL] [Abstract][Full Text] [Related]
34. Allometric extrapolation of factors VII, VIII and IX clearance in children from adults.
Mahmood I
J Thromb Haemost; 2012 Aug; 10(8):1609-13. PubMed ID: 22612736
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Apparent Oral Clearance of Small-Molecule Inhibitors in Pediatric Patients.
Kimura Y; Chisaki Y; Saki T; Matsumura C; Motohashi H; Onoue M; Yano Y
J Pharm Sci; 2018 Mar; 107(3):949-956. PubMed ID: 29133236
[TBL] [Abstract][Full Text] [Related]
36. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
37. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
[TBL] [Abstract][Full Text] [Related]
38. Physiologically-Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients.
Malik PRV; Edginton AN
CPT Pharmacometrics Syst Pharmacol; 2019 Nov; 8(11):835-844. PubMed ID: 31343836
[TBL] [Abstract][Full Text] [Related]
39. Prediction of total and renal clearance of renally secreted drugs in neonates and infants (≤3 months of age).
Mahmood I
J Clin Transl Res; 2022 Dec; 8(6):445-452. PubMed ID: 36452002
[TBL] [Abstract][Full Text] [Related]
40. Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates.
Kovar L; Schräpel C; Selzer D; Kohl Y; Bals R; Schwab M; Lehr T
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
